PT Medikaloka Hermina Tbk (IDX:HEAL)
Indonesia
· Delayed Price · Currency is IDR 1,060.00
-20.00 (-1.85%)
Mar 27, 2025, 4:02 PM WIB
PT Medikaloka Hermina Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 6,717,179 | 5,784,086 | 4,901,810 | 5,869,014 | 4,416,042 | Upgrade
|
| Revenue Growth (YoY) | 16.13% | 18.00% | -16.48% | 32.90% | 21.62% | Upgrade
|
| Cost of Revenue | 4,429,608 | 3,863,841 | 3,333,002 | 3,085,874 | 2,493,670 | Upgrade
|
| Gross Profit | 2,287,571 | 1,920,245 | 1,568,808 | 2,783,140 | 1,922,372 | Upgrade
|
| Selling, General & Admin | 975,524 | 877,739 | 850,882 | 946,678 | 845,214 | Upgrade
|
| Other Operating Expenses | -22,843 | -36,771 | -71,588 | -29,844 | -65,149 | Upgrade
|
| Operating Expenses | 1,227,995 | 1,102,775 | 980,864 | 1,018,100 | 887,026 | Upgrade
|
| Operating Income | 1,059,576 | 817,470 | 587,944 | 1,765,040 | 1,035,346 | Upgrade
|
| Interest Expense | -179,099 | -139,560 | -139,833 | -143,196 | -128,807 | Upgrade
|
| Interest & Investment Income | 28,029 | 31,978 | 32,548 | 23,232 | 32,881 | Upgrade
|
| EBT Excluding Unusual Items | 908,506 | 709,888 | 480,659 | 1,645,076 | 939,420 | Upgrade
|
| Gain (Loss) on Sale of Investments | -72 | 9 | -21 | 2,437 | 6,749 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1,071 | 845 | 632 | 399 | 418 | Upgrade
|
| Asset Writedown | -2,356 | -349 | -1,182 | -1,419 | -577 | Upgrade
|
| Pretax Income | 907,149 | 710,393 | 480,088 | 1,646,493 | 946,010 | Upgrade
|
| Income Tax Expense | 218,020 | 151,109 | 101,315 | 355,852 | 300,372 | Upgrade
|
| Earnings From Continuing Operations | 689,129 | 559,284 | 378,773 | 1,290,641 | 645,638 | Upgrade
|
| Minority Interest in Earnings | -153,187 | -121,938 | -80,177 | -294,667 | -172,416 | Upgrade
|
| Net Income | 535,942 | 437,346 | 298,596 | 995,974 | 473,222 | Upgrade
|
| Net Income to Common | 535,942 | 437,346 | 298,596 | 995,974 | 473,222 | Upgrade
|
| Net Income Growth | 22.54% | 46.47% | -70.02% | 110.47% | 85.31% | Upgrade
|
| Shares Outstanding (Basic) | 14,842 | 14,501 | 14,464 | 14,705 | 14,828 | Upgrade
|
| Shares Outstanding (Diluted) | 14,842 | 14,713 | 14,714 | 14,909 | 14,886 | Upgrade
|
| Shares Change (YoY) | 0.88% | -0.01% | -1.31% | 0.16% | -1.34% | Upgrade
|
| EPS (Basic) | 36.11 | 30.16 | 20.64 | 67.73 | 31.91 | Upgrade
|
| EPS (Diluted) | 36.11 | 29.73 | 20.29 | 66.80 | 31.79 | Upgrade
|
| EPS Growth | 21.46% | 46.52% | -69.63% | 110.14% | 87.84% | Upgrade
|
| Free Cash Flow | -1,144,368 | -271,707 | -261,272 | 642,792 | 236,833 | Upgrade
|
| Free Cash Flow Per Share | -77.10 | -18.47 | -17.76 | 43.11 | 15.91 | Upgrade
|
| Dividend Per Share | - | 8.500 | 7.000 | 6.000 | 5.000 | Upgrade
|
| Dividend Growth | - | 21.43% | 16.67% | 20.00% | 108.33% | Upgrade
|
| Gross Margin | 34.06% | 33.20% | 32.01% | 47.42% | 43.53% | Upgrade
|
| Operating Margin | 15.77% | 14.13% | 11.99% | 30.07% | 23.45% | Upgrade
|
| Profit Margin | 7.98% | 7.56% | 6.09% | 16.97% | 10.72% | Upgrade
|
| Free Cash Flow Margin | -17.04% | -4.70% | -5.33% | 10.95% | 5.36% | Upgrade
|
| EBITDA | 1,742,906 | 1,457,621 | 1,137,579 | 2,195,538 | 1,326,687 | Upgrade
|
| EBITDA Margin | 25.95% | 25.20% | 23.21% | 37.41% | 30.04% | Upgrade
|
| D&A For EBITDA | 683,330 | 640,151 | 549,635 | 430,498 | 291,341 | Upgrade
|
| EBIT | 1,059,576 | 817,470 | 587,944 | 1,765,040 | 1,035,346 | Upgrade
|
| EBIT Margin | 15.77% | 14.13% | 11.99% | 30.07% | 23.45% | Upgrade
|
| Effective Tax Rate | 24.03% | 21.27% | 21.10% | 21.61% | 31.75% | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.